June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Discrepancies in the Efficacy of Micropulse vs. Continuous-Wave Cyclophotocoagulation in Pediatric Glaucoma Patients
Author Affiliations & Notes
  • Marko Oydanich
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, United States
  • Maria Ines Vega Garces
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, United States
  • Siri Uppuluri
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, United States
  • Albert S. Khouri
    Institute of Ophthalmology & Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, United States
  • Footnotes
    Commercial Relationships   Marko Oydanich None; Maria Vega Garces None; Siri Uppuluri None; Albert Khouri Glaukos, Code C (Consultant/Contractor), Allergan, NJ Health Foundation, Code F (Financial Support), Allergan, Bausch & Lomb, Code S (non-remunerative)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4909. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marko Oydanich, Maria Ines Vega Garces, Siri Uppuluri, Albert S. Khouri; Discrepancies in the Efficacy of Micropulse vs. Continuous-Wave Cyclophotocoagulation in Pediatric Glaucoma Patients. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4909.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine and compare the efficacy of micropulse (MP-CPC) and continuous wave cyclophotocoagulation (CW-CPC) in pediatric patients diagnosed with glaucoma.

Methods : A total of 28 patients (81 eyes) diagnosed with pediatric glaucoma (patients diagnosed with glaucoma less than 18 years of age) were reviewed retrospectively over the course of 12 months after either undergoing MP-CPC or CW-CPC. Several of the patients underwent multiple CPC treatment, in which a pre-operative intraocular pressure (IOP) was used as the new baseline IOP measurement. Laser settings including duration of treatment, power (mW) and total energy (J), and total quadrants treated were recorded. Patient IOP measurements, number of glaucoma medications, and the onset of complications were collected at baseline, 1-month, 3-month, 6-month, and 12-month intervals. Student t-tests were used to determine the changes in IOP from baseline for each laser modality as well as to compare the average IOP between modalities at the same treatment time.

Results : All patients either undergoing MP-CPC or CW-CPC were matched for age (Mean ± SD; 1.76 ± 1.69 vs. 1.56 ± 2.49 years). Patients undergoing either MP-CPC or CW-CPC exhibited significant differences in their IOP at the 1, 3, and 6 month intervals. Patients that underwent MP-CPC, however, did not show a significant change in IOP at the 12-month interval when compared to baseline (30.90 ± 9.25 vs. 32.67 ± 6.89, p>0.05) while those patient that underwent CW-CPC did (36.88 ± 7.95 vs. 28.89 ± 11.24, p<0.05). When compared to MP-CPC, CW-CPC exhibited a significantly larger drop in IOP (0.89 ± 8.61 vs. 7.99 ± 7.95, p<0.05). There were no differences in total glaucoma medications at each visits between MP-CPC and CW-CPC patients. Eyes undergoing MP-CPC had significantly fewer complications with only 1 eye (5%) exhibiting a complication (corneal haze) and no complications of hypotony or phthisis bulbi. CW-CPC patients had more complications with 10 eyes (24%) exhibiting corneal haze and one eye (2%) suffering from phthisis bulbi. Similarly, to MPCPC, no patients that were treated with CWCPC experienced post-operative hypotony.

Conclusions : Both MP-CPC and CW-CPC exhibit efficacy in lowering IOP in patients with pediatric glaucoma. While patients undergoing MP-CPC treatment did not have a sustained IOP decrease they did exhibit fewer complications when compared to CW-CPC.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×